India · English
Lupin launches fixed-dose triple combination inhaler for COPD in India
According to the company, the therapy aims to serve more than 55 million people living with COPD in India, where the condition remains a leading cause of death and disability
Read the full report at The Hindu BusinessLine →
How 2 newsrooms ran it
2 of our sources carried this story over 1.9 hours. Business Standard filed first, at 11:30 IST. The headlines below are each outlet's own wording, in the order they published.
| Time IST | Outlet | Their headline |
|---|---|---|
| 11:30 | Business Standard | Lupin launches fixed-dose triple-combination inhaler for COPD in India |
| 13:25 | The Hindu BusinessLine | Lupin launches fixed-dose triple combination inhaler for COPD in India |
About this page
AKHBAARI groups the same story across publishers so you can see who is reporting it and how they differ. The summary above is machine-generated from the publisher's own feed text and is labelled as such. The full report stays with the publisher, who holds copyright in it. See our editorial policy.